Yamashita Hirofumi, Komine Okiru, Fujimori-Tonou Noriko, Yamanaka Koji
Department of Neurology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.
Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Front Cell Neurosci. 2023 Jan 4;16:1045647. doi: 10.3389/fncel.2022.1045647. eCollection 2022.
Non-cell autonomous mechanisms are involved in the pathogenesis of amyotrophic lateral sclerosis (ALS), an adult neurodegenerative disease characterized by selective motor neuron loss. While the emerging role of glial cells in ALS has been noted, the detailed cell-type-specific role of glial cells has not been clarified. Here, we examined mRNA expression changes using microarrays of the spinal cords of three distinct lines of mutant superoxide dismutase (SOD) 1 transgenic mice, an established ALS model. Our analysis used a transcriptome database of component cell types in the central nervous system (CNS), as well as SOD1 cell-type transcriptomes. More than half of the differentially expressed genes (DEGs) were highly expressed in microglia, and enrichment analysis of DEGs revealed that immunological reactions were profoundly involved and some transcription factors were upregulated. Our analysis focused on DEGs that are highly expressed in each cell type, as well as chemokines, caspases, and heat shock proteins. Disease-associated microglial genes were upregulated, while homeostatic microglial genes were not, and galectin-3 (Mac2), a known activated microglial marker, was predicted to be ectopically expressed in astrocytes in mutant SOD1 mice. In mutant SOD1 mice, we developed a prediction model for the pathophysiology of different cell types related to TREM2, apolipoprotein E, and lipoproteins. Our analysis offers a viable resource to understand not only the molecular pathologies of each CNS constituent cell type, but also the cellular crosstalk between different cell types under both physiological and pathological conditions in model mice for various neurodegenerative diseases.
非细胞自主机制参与了肌萎缩侧索硬化症(ALS)的发病过程,ALS是一种以选择性运动神经元丧失为特征的成人神经退行性疾病。虽然神经胶质细胞在ALS中的新作用已被注意到,但神经胶质细胞具体的细胞类型特异性作用尚未阐明。在此,我们使用已建立的ALS模型——三种不同品系的突变超氧化物歧化酶(SOD)1转基因小鼠的脊髓微阵列,检测了mRNA表达变化。我们的分析使用了中枢神经系统(CNS)中组成细胞类型的转录组数据库以及SOD1细胞类型转录组。超过一半的差异表达基因(DEG)在小胶质细胞中高表达,对DEG的富集分析表明免疫反应深度参与其中,且一些转录因子上调。我们的分析聚焦于在每种细胞类型中高表达的DEG,以及趋化因子、半胱天冬酶和热休克蛋白。与疾病相关的小胶质细胞基因上调,而稳态小胶质细胞基因未上调,并且已知的活化小胶质细胞标志物半乳糖凝集素-3(Mac2)预计在突变SOD1小鼠的星形胶质细胞中异位表达。在突变SOD1小鼠中,我们开发了一个与触发受体表达于髓系细胞2(TREM2)、载脂蛋白E和脂蛋白相关的不同细胞类型病理生理学预测模型。我们的分析不仅为理解每种CNS组成细胞类型的分子病理学,也为理解各种神经退行性疾病模型小鼠在生理和病理条件下不同细胞类型之间的细胞串扰提供了一个可行的资源。